BIA
GSK icon

Barry Investment Advisors’s GSK GSK Stock Holding History

Barry Investment Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$421K Sell
8,022
-5,521
-41% -$292K 0.09% 63
2026
Q1 		$754K Sell
13,543
-206
-1% -$11.2K 0.17% 50
2025
Q4 		$674K Sell
13,749
-4,344
-24% -$203K 0.15% 52
2025
Q3 		$781K Sell
18,093
-1,110
-6% -$43.4K 0.18% 55
2025
Q2 		$744K Sell
19,203
-1,232
-6% -$47.1K 0.19% 55
2025
Q1 		$800K Sell
20,435
-26
-0.1% -$952 0.21% 52
2024
Q4 		$692K Buy
20,461
+1,741
+9% +$62.7K 0.22% 56
2024
Q3 		$765K Buy
18,720
+687
+4% +$28.1K 0.23% 53
2024
Q2 		$694K Sell
18,033
-21
-0.1% -$883 0.23% 56
2024
Q1 		$774K Sell
18,054
-2,591
-13% -$107K 0.26% 50
2023
Q4 		$772K Sell
20,645
-1,263
-6% -$45.3K 0.26% 50
2023
Q3 		$801K Buy
21,908
+2,188
+11% +$77.7K 0.29% 52
2023
Q2 		$710K Sell
19,720
-731
-4% -$26.2K 0.24% 62
2023
Q1 		$735K Buy
20,451
+2,872
+16% +$100K 0.24% 62
2022
Q4 		$618K Buy
17,579
+3,960
+29% +$132K 0.2% 69
2022
Q3 		$406K Buy
+13,619
New +$516K 0.14% 79
2022
Q2 		– Sell
-12,654
Closed -$699K – 125
2022
Q1 		$699K Buy
12,654
+30
+0.2% +$1.63K 0.19% 68
2021
Q4 		$696K Buy
12,624
+27
+0.2% +$1.41K 0.18% 63
2021
Q3 		$610K Buy
12,597
+86
+0.7% +$4.32K 0.17% 66
2021
Q2 		$629K Buy
12,511
+233
+2% +$11.2K 0.17% 66
2021
Q1 		$554K Buy
12,278
+2,104
+21% +$95.5K 0.15% 68
2020
Q4 		$473K Buy
10,174
+5,279
+108% +$242K 0.14% 66
2020
Q3 		$232K Buy
+4,895
New +$245K 0.08% 76

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Barry Investment Advisors's GSK Position: Q2 2026 in Review

Barry Investment Advisors reduced its GSK (GSK) stake by 41% in Q2 2026, selling an estimated $292K and leaving 8,022 shares worth $421K. The position accounts for 0.09% of the portfolio, ranked #63.

Barry Investment Advisors first reported a position in GSK in Q3 2020 and has held it in 23 quarters since. The position peaked at $801K in Q3 2023. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Barry Investment Advisors held 8,022 shares of GSK worth $421K as of Q2 2026.
  • Barry Investment Advisors sold 5,521 GSK shares in Q2 2026, an estimated $292K.
  • GSK made up 0.09% of Barry Investment Advisors's portfolio in Q2 2026, its #63 holding.
  • Barry Investment Advisors first reported a position in GSK in Q3 2020 and has held it in 23 quarters since.
  • Barry Investment Advisors's GSK position peaked at $801K in Q3 2023.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Barry Investment Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.